|
HAUS5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.291600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.981200E-01 |
| Normal-vs-Stage2 |
1.457800E-01 |
| Normal-vs-Stage3 |
5.817000E-01 |
| Normal-vs-Stage4 |
1.229440E-01 |
| Stage1-vs-Stage2 |
6.917500E-02 |
| Stage1-vs-Stage3 |
5.039600E-01 |
| Stage1-vs-Stage4 |
8.652100E-02 |
| Stage2-vs-Stage3 |
6.966100E-02 |
| Stage2-vs-Stage4 |
1.208360E-02 |
| Stage3-vs-Stage4 |
2.679600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.453400E-01 |
| Normal-vs-AfricanAmerican |
2.305200E-01 |
| Normal-vs-Asian |
2.148500E-02 |
| Caucasian-vs-AfricanAmerican |
1.962370E-01 |
| Caucasian-vs-Asian |
3.324400E-02 |
| AfricanAmerican-vs-Asian |
8.378600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.649000E-01 |
| Normal-vs-Female |
9.042600E-01 |
| Male-vs-Female |
2.023800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.138600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.066600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.041800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.412200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.441400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.534400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.585600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.990200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.297000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.680400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.480200E-01 |
| Classical-VS-Follicular |
3.53260000029998E-07 |
| Classical-VS-Other |
3.436400E-01 |
| Classical-VS-Normal |
1.423170E-01 |
| Tall-VS-Follicular |
3.280300E-02 |
| Tall-VS-Other |
7.038600E-01 |
| Tall-VS-Normal |
9.873600E-01 |
| Follicular-VS-Other |
5.045600E-01 |
| Follicular-VS-Normal |
1.606490E-02 |
| Other-VS-Normal |
6.990400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.042800E-01 |
| Normal-vs-N1 |
2.529600E-01 |
| N0-vs-N1 |
1.072170E-01 |
|
|
